BRNS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

BRNS

57.7
AI Score
VS
BRNS Wins

CLYM

38.1
AI Score

Investment Advisor Scores

BRNS

58score
Recommendation
HOLD

CLYM

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric BRNS CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% 0.0% CLYM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 57.7/100 38.1/100 BRNS
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL BRNS

Relative Price Performance (Last 90 Days)

BRNS 1M: -11.8% · 3M: -13.1% CLYM 1M: +29.8% · 3M: +44.1%

Current Technical Phase

BRNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $0.59

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 74

RSI (14): 74.2 · Price: $16.33

Fundamentals Snapshot

Metric BRNS CLYM
Market Cap
Forward P/E -0.5 -15.5
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.05 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BRNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.